{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-050533","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2026-11-06T22:25:10+00:00","discovered_at":"2026-11-06T22:26:00.444301+00:00","generated_at":"2026-11-06T22:26:09.241388+00:00","sec_items":["5.07","5.08","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Mangoceuticals plans up to $10M Series D preferred Reg A offering; annual meeting set for Dec 30","bullets":["Series B holder (all 50 shares) consented Nov 2, 2026 to 8% Series D Convertible Cumulative Preferred; up to 1,000,000 shares at $10.00 each via Regulation A offering.","Neither the Series B Amendment nor the Series D certificate of designations has been filed with the Texas Secretary of State; neither is effective and the Company may not proceed.","Series B Amendment recognizes Series D's senior dividend and liquidation rights and is limited to approving the Series D designation only.","Combined 2025 and 2026 annual meeting set for Dec 30, 2026 at Dallas offices; record date Nov 12, 2026; shareholder proposals due Nov 16, 2026.","No sales in the contemplated Regulation A offering will occur before the SEC qualifies the Form 1-A offering statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-050533","json":"https://secwatch.observer/filing/0001493152-26-050533.json","markdown":"https://secwatch.observer/filing/0001493152-26-050533.md","text":"https://secwatch.observer/filing/0001493152-26-050533.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315226050533/0001493152-26-050533-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315226050533/form8-k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-06T22:26:09.241388+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}